Alerts will be sent to your verified email
Verify EmailVAISHALI
Vaishali Pharma
|
Auro Laboratories
|
IndoAmerican Advance
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
7.61 % | 15.74 % | -12.16 % |
5yr average Equity Multiplier
|
2.76 | 1.68 | 1.07 |
5yr Average Asset Turnover Ratio
|
0.89 | 1.03 | 0.15 |
5yr Avg Net Profit Margin
|
3.52 % | 9.45 % | -36.65 % |
Price to Book
|
2.51 | 4.1 | n/a |
P/E
|
199.13 | 95.84 | n/a |
5yr Avg Cash Conversion Cycle
|
133.52 Days | 34.28 Days | 0.0 |
Inventory Days
|
6.09 Days | 40.18 Days | 0.0 |
Days Receivable
|
217.95 Days | 87.78 Days | 0.0 |
Days Payable
|
174.07 Days | 76.54 Days | 167.71 Days |
5yr Average Interest Coverage Ratio
|
2.44 | 12.13 | -55.68 |
5yr Avg ROCE
|
16.76 % | 20.0 % | -12.15 % |
5yr Avg Operating Profit Margin
|
6.18 % | 14.46 % | -72.03 % |
5 yr average Debt to Equity
|
0.6 | 0.3 | 0.0 |
5yr CAGR Net Profit
|
88.82 % | 13.98 % | n/a |
5yr Average Return on Assets
|
3.1 % | 9.66 % | -11.02 % |
Shareholdings
|
|||
Promoter Holding
|
26.32 % | 52.18 % | 0.97 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-0.42 % | 0.19 % | -17.4 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Vaishali Pharma
|
Auro Laboratories
|
IndoAmerican Advance
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|